UpLift, Inc., an innovative startup at the intersection of marketing and payments, welcomes Kevin Krone, vice president and chief marketing officer of Southwest Airlines, to its board of directors, according to a Business Wire press release.
BAE Systems, Inc., announced that Michael G. Vickers has been appointed to its board of directors for a three-year term, beginning December 1, according to a Business Wire press release.
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that Michael Bonney, current Board member and former chief executive of Cubist Pharmaceuticals, has been appointed as Chairman effective January 1, 2016, according to a Business Wire press release.
Larry Van Kirk, managing director of Valuation Research Corporation, recently spoke to Private Company Director and provided information on valuation of private companies. Below are his answers to a Q&A interview:
Why should a private company board consider a valuation of the company?
Nanigans, Inc., the leading provider of advertising automation software for in-house marketers, has appointed Jim Payne to its Board of Directors, according to a Business Wire press release.
Socrates Health Solutions, Inc., which is developing the Socrates Companion, a pain-free, accurate and affordable noninvasive blood glucose monitoring device, announces the appointment of Douglas Sutherland to its Board of Directors, according to a Business Wire press release.
Alzheon, Inc., a clinical-stage biopharmaceutical company focused on brain health, memory and aging, announced that Jean-Pierre Garnier, PhD, has been appointed Chairman of the Board of Directors of the company, according to a Business Wire press release.
Dr. Garnier brings world-class expertise and global perspective to help build Alzheon into a leading clinical-stage Alzheimer’s company.
MPM Holdings Inc. (“Momentive” or the “Company”) announced that Jeffrey M. Nodland has been elected to Momentive’s Board of Directors, effective December 7, 2015, according to a Business Wire press release.
Mr. Nodland was also appointed to the Environment, Health and Safety Committee of the Board. Mr. Nodland replaces Daniel C. Murphy who resigned from Momentive’s Board of Directors on August 27, 2015.
CRISPR Therapeutics, a biopharmaceutical company focused on developing transformative gene-based medicines for patients with serious diseases, announced the appointment of Tony Coles, M.D., to the company’s Board of Directors, according to a Business Wire press release.
